Efficacy and safety of combining olodaterol Respimat<sup>&reg;</sup> and tiotropium HandiHaler<sup>&reg;</sup> in patients with COPD: results of two randomized, double-blind, active-controlled studies

Richard ZuWallack; Lisa Allen; Gemzel Hernandez; Naitee Ting; Roger Abrahams

doi:10.2147/COPD.S72482

open access to scientific and medical research

Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 9 » Issue 1

Original Research

Efficacy and safety of combining olodaterol Respimat^® and tiotropium HandiHaler^® in patients with COPD: results of two randomized, double-blind, active-controlled studies

Total article views		HTML views	PDF downloads	Totals
18,361	Dovepress*	14,813+	3,243	18,056
	PubMed Central*	3,548	1,968	5,516
	Totals	18,361	5,211	23,572
*Since 14 October 2014 +Since July 2016

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
3	0	0	0	0	3

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Efficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled studies

Efficacy and safety of combining olodaterol Respimat^® and tiotropium HandiHaler^® in patients with COPD: results of two randomized, double-blind, active-controlled studies